drug · gene
cretostimogene grenadenorepvec
Phase 3updated 6mo agoby $CGON CG Oncology, Inc.🔗 ChEMBL
Phase 3community read0 votes
Gene drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying cretostimogene grenadenorepvec
- phase2Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
- —An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
- phase2Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- phase3Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
- phase3A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
News(1)
- CG Oncology's bladder cancer treatment beats expectations in Phase 3CG Oncology said its oncolytic immunotherapy succeeded in a late-stage trial in certain patients with non-muscle invasive bladder cancer, potentially expanding the asset’s market significantly. Cre…endpoints · 3d ago
Data sources
last refreshed 7h ago
Found something off?
comments(0)
5-min edit window · permanent after that